Windtree Therapeutics Inc... (WINT)
NASDAQ: WINT
· Real-Time Price · USD
0.75
-0.01 (-1.45%)
At close: Jun 02, 2025, 3:59 PM
0.75
0.24%
After-hours: Jun 02, 2025, 06:07 PM EDT
-1.45% (1D)
| Bid | 0.68 |
| Market Cap | 2.74M |
| Revenue (ttm) | 45K |
| Net Income (ttm) | -20.75M |
| EPS (ttm) | -6321.5 |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | Hold |
| Ask | 0.89 |
| Volume | 321,339 |
| Avg. Volume (20D) | 2,776,603 |
| Open | 0.72 |
| Previous Close | 0.76 |
| Day's Range | 0.68 - 0.77 |
| 52-Week Range | 0.68 - 737.50 |
| Beta | 0.82 |
About WINT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol WINT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for WINT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+18.92%
Windtree Therapeutics shares are trading higher af...
Unlock content with
Pro Subscription
2 months ago
+28.99%
Windtree shares are trading higher after the company entered a license and supply agreement to become a sourcing partner for Evofem Biosciences for Evofem's PHEXXI.
